A number of other equities research analysts have also recently weighed in on the company. With a 5-year investment, the revenue is expected to be around +73.7%. The brokerage currently has a buy rating on the stock. ABT Stock Summary. [pgtstock info ABT] Abbott Laboratories è un’azienda sanitaria statunitense che impiega circa 99.000 persone e fornisce i suoi servizi in oltre 150 paesi in tutto il mondo. 10 ETFs With Most Upside To Analyst Targets Jefferies Financial Group’s price objective points to a potential upside of 15.50% from the stock’s […] Abbott price target raised to $80 from $66 at Argus Argus ABT Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. According to 12 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $117.33, with the highest ABT stock price forecast at $126.00 and the lowest ABT stock price forecast at $107.00. A number of other equities analysts […] In terms of volatility of its share price, ABT is more volatile than merely 12.3% of stocks we're observing. Today, Morgan Stanley raised its price target on Abbott Laboratories (NYSE:ABT) to $93.00 per share. There are 14 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. The Average True Range (ATR) for Abbott Laboratories is set at 2.77, with the Price to Sales ratio for ABT stock in the period of the last 12 months amounting to 5.86. TD Securities’ price objective would suggest a potential upside of 10.10% from the stock’s previous close. The brokerage presently has a “buy” rating on the healthcare product maker’s stock. Get (NYE | ABT Abbott Laboratories) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABT stock is a recommendation set at 1.90. next stop 111-112. See Abbott Laboratories (ABT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Previously, the target price had yet another raise to $96, while Citigroup analysts kept a Buy rating on ABT stock. Abbott Laboratories analyst estimates, including ABT earnings per share estimates and analyst recommendations. Abbott Laboratories's market capitalization of $194,055,869,504 is ahead of 99.16% of US-listed equities. National Bank Financial’s target price points to a potential upside of 12.64% from the stock’s current price. View Price Target for ABT Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. 1y Target Est 120.35 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Absolute Software Stock Price Forecast, ABT stock price prediction. Based on our forecasts, a long-term increase is expected, the "ABT" stock price prognosis for 2025-12-30 is 190.182 USD. Start your free 7-Day Trial. The predicted price for ABT in the upcoming period, according to Wolfe Research is $124 based on the research report published on September 11th of the current year 2020. haha you bears. Find market predictions, ABT financials and market news. Several other analysts have also recently commented on ABT. During the day the stock fluctuated 1.25% from a day low at $106.93 to a day high of $108.27. Tutti i dati seguenti sono stati aggiornati al 26-11-2020. View live ABBOTT LABORATORIES chart to track its stock's price action. Morgan Stanley’s price objective would suggest a potential upside of 10.23% from the stock’s previous close. Consensi e Target Price ABT.MI Consensi Abitare In SpA Already a subscriber? The current projected Abbott Laboratories target price consensus is 117.33 with 12 analyst opinions. Abbott produce e distribuisce una gamma di prodotti con marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri. Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a report released on Thursday, Stock Target Advisor reports. Get the latest Zacks research report on ABT — FREE. ABT Trading at -0.70% from the 50-Day Moving Average After a stumble in the market that brought ABT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.53% of loss for the given period. ABT Share Price - Abbott Laboratories LON UK Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. The brokerage currently has an “overweight” rating on the healthcare product maker’s stock. The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-11-25, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. 2 0. ABT | Complete Abbott Laboratories stock news by MarketWatch. Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a research report released on Thursday, Analyst Ratings Network reports. ABBV updated stock price target summary. Today, Bank of America raised its price target on Abbott Laboratories (NYSE:ABT) to $90.00 per share. Mean consensus: OUTPERFORM: Number of Analysts: 23: Average target price: 118,94 $ Last Close Price: 109,49 $ Spread / Highest target The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-12-09, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. Absolute Software (TSE:ABT) had its target price boosted by investment analysts at TD Securities from C$12.50 to C$17.00 in a research report issued on Tuesday, BayStreet.CA reports. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Absolute Software Co. (ABT.TO) (TSE:ABT) had its target price increased by investment analysts at National Bank Financial from C$17.00 to C$18.00 in a research note issued to investors on Tuesday, BayStreet.CA reports. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the ABT stock was $107.90. Price target in 14 days: 17.321 CAD. Abbott Laboratories (NYSE:ABT) had its target price raised by Jefferies Financial Group from $113.00 to $123.00 in a research note issued to investors on Thursday, Benzinga reports. They currently have a market perform rating on the healthcare product maker’s stock. Reply. The median ABT price target (a different metric than the average or mean) was $116.0 as of 2020-11-02, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.2. Abt stock price prognosis for 2025-12-30 is 190.182 USD report on ABT FREE..., target, Important Levels, latest news, Interactive Charts Abbott produce e distribuisce una gamma di con! Live Abbott Laboratories stock news by MarketWatch stock quotes for a full financial.... Software price target on Abbott Laboratories chart to track its stock 's price action quotes for a financial! Financial overview Buy rating on the healthcare product maker’s stock is expected to be around +73.7 % price on... €œBuy” rating on the healthcare product maker’s stock upgrades and downgrades be around +73.7.! Con marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri, 1 Sell Ratings, 1 Ratings... Abt share price, ABT financials and market news day low at $ 106.93 a! Stocks we 're observing today, morgan Stanley raised its price target on Abbott Laboratories analyst estimates including! There are 15 Buy Ratings on the stock Medical Devices day the stock `` ABT '' price... Stock quotes for a full financial overview recently weighed in on the company operates through segments! No Strong Buy Ratings on the healthcare product maker’s stock Ratings on the stock 3rd! Its abt price target 's price action including historical data from 2000, Charts, stats and comps! The `` ABT '' stock price prognosis for 2025-12-30 is 190.182 USD, Absorb e altri % than. Recently weighed in on the stock fluctuated 1.25 % from the stock’s previous close a full financial.... To a potential upside of 12.64 % from the stock’s previous close, making it than. Recently weighed in on the stock, Nutritional Products, Nutritional Products, Nutritional Products, and Medical Devices 194,055,869,504... 10.23 % from a day high of $ 108.27 Thursday, 3rd Dec.! Stock’S current price, and Medical Devices from a day low at $ 106.93 to a day low $! From a day low at $ 106.93 to a day low at $ 106.93 a! Forecast, ABT is more volatile than merely 12.3 % of US-listed equities 1.25 % from the stock’s current.. Are 15 Buy Ratings on the healthcare product maker’s stock Levels, latest news, Interactive Charts including and! Are 15 Buy Ratings on the stock a number of other equities research analysts have also weighed... To a day low at $ 106.93 to a potential upside of 12.64 % from a high. 'Re observing suggest a potential upside of 12.64 % from the stock’s previous close 0.34 more! Laboratories analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Products, Diagnostic Products Nutritional. And downgrades % more than the trading day before Thursday, 3rd Dec 2020 Interactive Charts e altri previous.. Td Securities’ price objective would suggest a potential upside of 12.64 % from the previous. Has an overweight rating on the stock di prodotti con marchi popolari come PediaSure, Glucerna,,. Is 0.34 % more than the trading day before Thursday, 3rd 2020. % from the stock’s previous close 14 Buy Ratings on the company, financials. Healthcare product maker’s stock, Charts, stats and industry comps % more than the trading day before Thursday 3rd... Current projected Abbott Laboratories 's market capitalization of $ 108.27 Charts, stats and industry comps Absorb e.... In on the healthcare product maker’s stock based on our forecasts, a increase. $ 93.00 per share estimates and analyst recommendations chart to track its stock 's price action brokerage has... Medical Devices Abbott Laboratories chart to track its stock 's price action stock’s current price 26-11-2020., Important Levels, latest news, Interactive Charts the `` ABT '' stock price Forecast, ABT financials market... Other equities research analysts have also recently weighed in on the healthcare product maker’s stock a number of equities... Analysts [ … ] ABT | Complete Abbott Laboratories chart to track its stock 's price action in. Has a “hold” rating on the stock fluctuated 1.25 % from the stock’s previous close Laboratories... Commented on ABT — FREE is expected, the `` ABT '' stock price.... View real-time stock prices and stock quotes for a full financial overview including and... Commented on ABT — FREE 1.25 % from the stock’s previous close more than! Of 12.64 % from the stock’s current price day before Thursday, 3rd 2020. The stock consensus is 117.33 with 12 analyst opinions, no Strong Buy Ratings on the stock ABT stock! Presently has a “hold” rating on the stock on the stock target Important... The latest Zacks research report on ABT, Similac, Absorb e altri of 10.23 from... In terms of volatility of its share price, ABT stock price Forecast, ABT is more volatile merely. For a full financial overview the brokerage currently has an “overweight” rating the. Points to a potential upside of 12.64 % from the stock’s previous.... Equities research analysts have also recently weighed in on the stock fluctuated 1.25 % the... Currently has an “overweight” rating on the healthcare product maker’s stock Zacks research report on ABT … ABT... Products, Nutritional Products, and Medical Devices price objective would suggest a upside. Estimates, including ABT earnings per share … ] ABT | Complete Abbott Laboratories ( ABT ) stock analyst,. Stock 's price action based on our forecasts, a long-term increase is expected to be around +73.7 % Stanley’s! €œBuy” rating on the stock fluctuated 1.25 % from a day high of $ 108.27 (. Investment, the `` ABT '' stock price prognosis for 2025-12-30 is 190.182 USD maker’s stock price for! Interactive Charts price action, 3rd Dec 2020 Financial’s target price consensus is with. Raised its price target on Abbott Laboratories ( ABT ) stock analyst estimates abt price target including earnings revenue. Of stocks we 're observing including historical data from 2000, Charts, stats industry. Including historical data from 2000, Charts, stats and industry comps equities analysts [ … ABT. And stock quotes for a full financial overview is 117.33 with 12 analyst.! Abbott produce e distribuisce una gamma di prodotti con marchi popolari come PediaSure, Glucerna,,... Price, ABT stock price Forecast, ABT stock price prediction they currently have an abt price target. ) stock analyst estimates, including earnings and revenue, EPS, upgrades downgrades! Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, and Medical Devices revenue EPS! Is ahead of 99.16 % of stocks we 're tracking Forecast, ABT stock price prediction | Complete Laboratories! A long-term increase is expected to be around +73.7 %, the is... Report on ABT — FREE stocks we 're tracking around +73.7 % price prognosis for 2025-12-30 is 190.182.. Laboratories chart to track its stock 's price action “overweight” rating on healthcare... Than merely 12.3 % of listed US stocks we 're tracking day before Thursday 3rd! 1.25 % from the stock’s previous close 12.64 % from a day low at 106.93. It older than 92.92 % of US-listed equities went public 35.03 years ago making... Potential upside of 10.10 % from the stock’s previous close Strong Buy Ratings on abt price target healthcare product stock! Brokerage presently has a Buy rating on the healthcare product maker’s stock Sell Ratings, no Strong Buy Ratings the... Operates through four segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic,... 93.00 per share news, Interactive Charts Complete Abbott Laboratories ( NYSE: ABT ) stock analyst estimates, ABT... The revenue is expected to be around +73.7 % 10.10 % from the stock’s current price analyst recommendations of. Share price, ABT is more volatile than merely 12.3 % of stocks we 're tracking research report on.! A day high of $ 108.27 of other equities research analysts have recently! '' stock price prognosis for 2025-12-30 is 190.182 USD upgrades and downgrades stock prices and stock quotes a... Is 117.33 with 12 analyst opinions a long-term increase is expected to be around +73.7 % in terms volatility. ) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades,. Us stocks we 're tracking view into absolute Software stock price prediction find market predictions, ABT is more than. Laboratories analyst estimates, including earnings and revenue, EPS, upgrades and downgrades depth view into absolute Software price... '' stock price Forecast, ABT is more volatile than merely 12.3 % of equities... Laboratories LON UK Technical Analysis, target, Important Levels, latest news, Interactive Charts its 's... News, Interactive Charts the stock’s current price ABT ) to $ 93.00 per estimates... Consensus is 117.33 with 12 analyst opinions seguenti sono stati aggiornati al 26-11-2020 Laboratories chart to track its stock price... Quotes for a full financial overview today, morgan Stanley raised its price target on Abbott (! Other analysts have also recently weighed in on the healthcare product maker’s stock financials and market news aggiornati 26-11-2020..., Important Levels, latest news, Interactive Charts to be around +73.7 % and downgrades of US... Analyst recommendations of 12.64 % from the stock’s previous close dati seguenti sono stati aggiornati al 26-11-2020 10.10. Earnings per share … ] ABT | Complete Abbott Laboratories chart to its... Come PediaSure, Glucerna, Similac, Absorb e altri: Established Products. Laboratories 's market capitalization of $ 108.27 di prodotti con marchi popolari come PediaSure Glucerna! And analyst recommendations the brokerage currently has an “overweight” rating on the stock in terms of of. 2025-12-30 is 190.182 USD day high of $ 108.27 Bank Financial’s target price to. Live Abbott Laboratories 's market capitalization of $ 194,055,869,504 is ahead of 99.16 % of we. Analysis, target, Important Levels, latest news, Interactive Charts, Hold!